Based in North Brunswick, NJ, Ascendia Pharmaceuticals, Inc. (“Ascendia”) is a specialty contract development and manufacturing organization (CDMO) dedicated to developing and manufacturing enhanced formulations for pre-clinical, clinical stage drug candidates, and marketed drug products. The investment was made by Signet Healthcare Partners (“Signet”), a New York-based growth equity firm specializing in healthcare investments. The proceeds will be used to fund Ascendia’s facility expansion to support the growing demand in the sector.
Read the full article: Ascendia Pharmaceuticals Secures Growth Equity Investment from Signet Healthcare Partners //
Source: https://www.prnewswire.com/news-releases/ascendia-pharmaceuticals-secures-growth-equity-investment-from-signet-healthcare-partners-301265086.html